SBLATTERO, DANIELE
 Distribuzione geografica
Continente #
EU - Europa 3.241
NA - Nord America 2.730
AS - Asia 1.906
SA - Sud America 326
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
AN - Antartide 1
Totale 8.248
Nazione #
US - Stati Uniti d'America 2.677
RU - Federazione Russa 898
IE - Irlanda 718
CN - Cina 541
SG - Singapore 533
DE - Germania 367
SE - Svezia 351
HK - Hong Kong 327
UA - Ucraina 271
VN - Vietnam 261
BR - Brasile 248
IT - Italia 207
FI - Finlandia 174
FR - Francia 107
GB - Regno Unito 67
IN - India 64
KR - Corea 41
AR - Argentina 37
CA - Canada 29
ID - Indonesia 26
MX - Messico 20
BD - Bangladesh 19
EC - Ecuador 19
TR - Turchia 19
IR - Iran 17
PL - Polonia 15
BE - Belgio 14
ZA - Sudafrica 14
ES - Italia 12
NL - Olanda 12
IQ - Iraq 9
JP - Giappone 9
AT - Austria 8
PY - Paraguay 7
CO - Colombia 6
CZ - Repubblica Ceca 6
EU - Europa 6
PK - Pakistan 6
BJ - Benin 5
MY - Malesia 5
PH - Filippine 4
RO - Romania 4
SA - Arabia Saudita 4
TN - Tunisia 4
UZ - Uzbekistan 4
VE - Venezuela 4
AU - Australia 3
DO - Repubblica Dominicana 3
LT - Lituania 3
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
KW - Kuwait 2
LB - Libano 2
OM - Oman 2
PE - Perù 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
UY - Uruguay 1
Totale 8.248
Città #
Dublin 711
Jacksonville 484
San Jose 363
Hong Kong 327
Dearborn 219
Beijing 201
Singapore 199
Ashburn 141
Wilmington 125
Moscow 108
Chandler 106
Lauterbourg 88
Lawrence 88
Princeton 88
Ho Chi Minh City 81
Ann Arbor 80
Los Angeles 75
San Mateo 75
Andover 58
Piemonte 53
Hanoi 46
Buffalo 43
Seoul 40
Düsseldorf 32
Dallas 31
New York 31
São Paulo 30
Council Bluffs 18
Tianjin 18
Boardman 17
Guangzhou 17
Kunming 17
Hefei 16
Frankfurt am Main 15
Munich 15
Novara 15
Turin 15
Brussels 14
Da Nang 14
Monmouth Junction 14
Santa Clara 14
Chennai 13
Houston 13
Nanjing 13
Toronto 13
Helsinki 12
Orem 12
Warsaw 12
Milan 11
Woodbridge 11
Denver 9
Johannesburg 9
Kocaeli 9
Norwalk 9
Seattle 9
Atlanta 8
Bremen 8
Brooklyn 8
Dong Ket 8
Haiphong 8
Jakarta 8
London 8
Mexico City 8
Nuremberg 8
Shenzhen 8
Tokyo 8
Vienna 8
Boston 7
Fairfield 7
Hangzhou 7
Manchester 7
Montreal 7
Philadelphia 7
Quito 7
Redondo Beach 7
Stockholm 7
Thái Bình 7
Tornaco 7
Amsterdam 6
Ardabil 6
Biên Hòa 6
Fuzhou 6
Grafing 6
Jinan 6
Leawood 6
Mumbai 6
Nanchang 6
Shenyang 6
Vercelli 6
Zanjan 6
Barnet 5
Can Tho 5
Cotonou 5
Curitiba 5
Guayaquil 5
Poplar 5
Rome 5
Trieste 5
Ankara 4
Brasília 4
Totale 4.590
Nome #
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 159
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 143
ICOS-Ligand Triggering Impairs Osteoclast Differentiation and Function In Vitro and In Vivo 143
InteractomeSeq: a web server for the identification and profiling of domains and epitopes from phage display and next generation sequencing data 141
Engineering mammalian cell factories with SINEUP noncoding RNAs to improve translation of secreted proteins 132
A reliable screening procedure for coeliac disease in clinical practice 130
An Air-well sparging minifermenter system for high-throughput protein production. 130
RECOMBINANT ANTIBODIES AGAINST HUMAN TYPE II TRANSGLUTAMINASE AND USES THEREOF 129
A definitive set of oligonucleotide primers for amplifying human V regions 127
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ 127
A non-hypothesis-driven practical laboratory activity on functional metagenomics: “fishing” protein-coding DNA sequences from microbiomes 125
The RNA-binding protein ILF3 binds to transposable element sequences in SINEUP lncRNAs 118
Extending filamentous phage host range by the grafting of a heterologous receptor binding domain 117
Antibodies in proteomics I: generating antibodies 116
SINEUPs: A new class of natural and synthetic antisense long non-coding RNAs that activate translation 116
Antibody library selection by the beta-lactamase protein fragment complementation assay 113
Gliadin-dependent UPR induction directly triggers the expression of TG2 and pro-inflammatory cytokines, dysregulates intestinal permeability, and reduces CFTR expression in intestinal epithelial cells of celiac disease patients 112
SINEUPs are modular antisense long non-coding RNAs that increase synthesis of target proteins in cells 111
High-throughput assessment of the antibody profile in ovarian cancer ascitic fluids 111
A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects 110
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 107
Recombinant antibodies against CD55 and CD59 and uses thereof 107
A deep-blue OLED-based biochip for protein microarray fluorescence detection. 107
Identification of novel proteins binding the AU-rich element of α-prothymosin mRNA through the selection of open reading frames (RIDome) 105
Novel Bispecific Antibody for Synovial-Specific Target Delivery of Anti-TNF Therapy in Rheumatoid Arthritis 104
Filtering "genic" open reading frames from genomic DNA samples for advanced annotation 103
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors 102
Autoantibodies as predictors of disease 100
Dpp10 - A New Putative Regulatory ß-subunit Of Ito In Failing And Non-failing Human Heart 100
Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of I (to) channel complex 98
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. 97
N-glycosylation of the mammalian dipeptidyl aminopeptidase-like protein 10 (DPP10) regulates trafficking and interaction with Kv4 channels 97
Anti transglutaminase antibodies cause ataxia in mice 96
Antibody library selection by the {beta}-lactamase protein fragment complementation assay 96
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 96
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 95
Profiling the autoantibody repertoire by screening phage-displayed human cDNA libraries 94
Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries 94
Selecting soluble/foldable protein domains through single-gene or genomic ORF filtering: structure of the head domain of Burkholderia pseudomallei antigen BPSL2063 94
The CXCR3/PLC/IP3-IP3R axis is responsible for the ignition of UPR in intestinal epithelial cells exposed to gliadin peptide, during the onset of celiac disease 92
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives 91
An albumin-derived peptide scaffold capable of binding and catalysis. 91
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 91
Deglycosylation effects of tunicamycin and neuraminidase on Kv4.3 channel complex 90
Anti-transglutaminase antibodies and age 89
Recombinant antibodies against CD55 and CD59 and uses thereof 87
Role of the C-terminal fragment of osteopontin in multiple sclerosis 86
In vivo recombination as a tool to generate molecular diversity in phage antibody libraries 84
Anti-idiotypic response in mice expressing human autoantibodies 83
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 82
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease 82
The transmembrane beta-subunits KCNE1, KCNE2, and DPP6 modify pharmacological effects of the antiarrhythmic agent tedisamil on the transient outward current Ito 82
Antibodies in proteomics II: screening, high-throughput characterization and downstream applications 82
Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59 80
Profiling celiac disease antibody repertoire. 80
Simple scale-up of recombinant antibody production using an UCOE containing vector 80
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells. 79
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor 78
Treatment of arthritis models by targeting synovial endothelium with a neutralizing recombinant antibody to C5. 77
Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. 77
Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies 77
Phage display technology for human monoclonal antibodies 77
Predicting antigenic peptides suitable for the selection of phage antibodies 77
The gut as site of production of autoimmune antibodies 76
Binders based on dimerised immunoglobulin VH domains 75
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease 75
The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies 74
Exploiting recombination in single bacteria to make large phage antibody libraries 73
Plasmid incompatibility: more compatible than previously thought? 73
Primer sets for cloning the human repertoire of T cell Receptor Variable regions 73
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease 72
Characterizing monoclonal antibody epitopes by filtered gene fragment phage display 72
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 70
Rapid interactome profiling by massive sequencing 70
Method for the preparation by in vivo recombination of nucleic acid and polypeptide libraries and uses thereof 67
Selecting open reading frames from DNA 66
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine 65
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 65
Defining the Helicobacter pylori Disease-Specific Antigenic Repertoire 64
Testing for anti-human transglutaminase antibodies in saliva is not useful for diagnosis of celiac disease 63
Mass screening for coeliac disease using antihuman transglutaminase antibody assay 63
Dual sugar gut-permeability testing on blood drop in animal models 61
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics. 61
Mucosal tissue transglutaminase expression in celiac disease 61
Development of a novel rapid non-invasive screening test for coeliac disease 60
Characterization of the Anti-Tissue Transglutaminase Antibody Response in Nonobese Diabetic Mice 60
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models 59
Selection and characterization of a novel agonistic human recombinant anti-TRAIL_R2 minibody with anti_leukemic activity 59
Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. 56
Using archaeal histones for precise DNA fragmentation 56
Gluten ataxia: passive transfer in a mouse model 56
Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet 51
Totale 8.292
Categoria #
all - tutte 39.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 19 97 19
2021/2022625 38 16 108 79 33 2 65 17 44 40 66 117
2022/20231.227 94 44 68 28 43 111 22 66 699 3 31 18
2023/2024298 29 14 22 8 61 5 72 5 0 1 24 57
2024/2025867 10 3 28 6 18 47 117 47 262 135 33 161
2025/20263.320 125 190 400 545 271 188 599 540 242 220 0 0
Totale 8.292